Injective INJ
Current Price
$2.91 +3.84%
$0.1500 Daily Range (5.15%)
$2.78$2.93
$43.09M Daily Volume
629 BTC
Vol/MktCap: 14.81%
Market Performance
0.08% Relative BTC Volume
The total volume of Injective is $43.09M over the past 24 hours, compared to $53.84B total Bitcoin volume.
Hourly Moving Average
8 SMA $2.90 +0.27%
13 SMA $2.90 +0.34%
21 SMA $2.87 +1.32%
55 SMA $2.85 +2.05%
144 SMA $2.95 -1.48%
Price Performance
-0.32% 1 Hour Change
$2.91 from $2.92
-6.47% 7 Day Change
-$0.1883 from $3.10
-13.95% 14 Day Change
-$0.4059 from $3.32
-11.34% 30 Day Change
-$0.3301 from $3.24
All Time High
March 14, 2024
$52.62 -94.45%
-$49.70 vs. now
24H Change
10.87M USD +3.88%
159 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
15.09M INJ
traded over past 24 hours
15.09% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $2.90, reflecting a 1.69% increase over the past 24 hours, with a daily trading range of $2.78 to $2.92. The volume stands at approximately 39.3 million, which represents 13.54% of the market cap, indicating a moderate trading interest in the asset.
The hourly moving averages show a positive short-term trend, with the 8 SMA at $2.89 (+0.42%) and the 13 SMA at $2.86 (+1.28%). However, the 144 SMA at $2.96 indicates a potential resistance level, as it has a negative change of -1.97%, suggesting a short-term pullback might be on the horizon.
The 1-hour RSI is at 74, indicating that INJ is in overbought territory, which often leads to price corrections. In contrast, the 7-day RSI at 47 suggests that the asset is neither overbought nor oversold, with the 7-day price change showing a decline of 3.5%.
Fundamentally, INJ's price has decreased significantly over the past two weeks, with a 14-day change of -15.90% and a 30-day change of -8.21%. This downward trend in the longer time frames indicates that market sentiment may be weakening despite the recent short-term uptick.
In conclusion, while the short-term indicators suggest potential upward momentum, the overbought condition coupled with the negative long-term price trends indicates caution. Therefore, the rating for Injective (INJ) is a Hold, as it may be prudent to wait for a more favorable entry point or confirmation of a trend reversal before considering a buy.
The hourly moving averages show a positive short-term trend, with the 8 SMA at $2.89 (+0.42%) and the 13 SMA at $2.86 (+1.28%). However, the 144 SMA at $2.96 indicates a potential resistance level, as it has a negative change of -1.97%, suggesting a short-term pullback might be on the horizon.
The 1-hour RSI is at 74, indicating that INJ is in overbought territory, which often leads to price corrections. In contrast, the 7-day RSI at 47 suggests that the asset is neither overbought nor oversold, with the 7-day price change showing a decline of 3.5%.
Fundamentally, INJ's price has decreased significantly over the past two weeks, with a 14-day change of -15.90% and a 30-day change of -8.21%. This downward trend in the longer time frames indicates that market sentiment may be weakening despite the recent short-term uptick.
In conclusion, while the short-term indicators suggest potential upward momentum, the overbought condition coupled with the negative long-term price trends indicates caution. Therefore, the rating for Injective (INJ) is a Hold, as it may be prudent to wait for a more favorable entry point or confirmation of a trend reversal before considering a buy.
Updated 325 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

XRP holders face $50B in unrealized losses as it trades below $1.40
60% of XRP's circulating supply trades underwater at $1.35, with spot ETF outflows and weak sentiment adding pressure on the bulls amid the current slump.

38 days of extreme fear as crypto sentiment hits 4-year low – Should you be worried?
Investors are retreating, activity is cooling, and fear dominates crypto, but hidden on-chain signals hint at something unexpected.

Bitmine adds 61K ETH as prices hit $2K, Tom Lee says mini crypto winter may be ending
Bitmine's strategic ETH accumulation and staking expansion signal growing confidence in crypto's recovery, potentially boosting market stability.

Retail capitulates on XRP as $51B in losses mount – Yet ONE group refuses to sell
Retail XRP holders are exiting at a loss as prices drop below $1.38, while large wallets accumulate during the market drawdown.